Alnylam Pharmaceuticals, Inc. (ETR:DUL)

Alnylam Pharmaceuticals Statistics

Total Valuation

ETR:DUL has a market cap or net worth of EUR 47.13 billion. The enterprise value is 47.17 billion.

Market Cap	47.13B
Enterprise Value	47.17B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	132.11M
Shares Outstanding	n/a
Shares Change (YoY)	+4.82%
Shares Change (QoQ)	+5.14%
Owned by Insiders (%)	0.31%
Owned by Institutions (%)	99.07%
Float	129.40M

Valuation Ratios

The trailing PE ratio is 1,269.35 and the forward PE ratio is 38.49.

PE Ratio	1,269.35
Forward PE	38.49
PS Ratio	17.23
PB Ratio	236.43
P/TBV Ratio	236.43
P/FCF Ratio	249.81
P/OCF Ratio	208.00
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 142.21, with an EV/FCF ratio of 250.03.

EV / Earnings	1,270.47
EV / Sales	17.10
EV / EBITDA	142.21
EV / EBIT	207.42
EV / FCF	250.03

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 11.86.

Current Ratio	2.54
Quick Ratio	2.37
Debt / Equity	11.86
Debt / EBITDA	7.18
Debt / FCF	12.53
Interest Coverage	1.63

Financial Efficiency

Return on equity (ROE) is 32.73% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	32.73%
Return on Assets (ROA)	3.65%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.03%
Revenue Per Employee	1.23M
Profits Per Employee	16,650
Employee Count	2,230
Asset Turnover	0.71
Inventory Turnover	6.83

Taxes

Income Tax	-64.36M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.44
52-Week Price Change	n/a
50-Day Moving Average	393.75
200-Day Moving Average	n/a
Relative Strength Index (RSI)	36.36
Average Volume (20 Days)	3

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.63

Income Statement

In the last 12 months, ETR:DUL had revenue of EUR 2.74 billion and earned 37.13 million in profits. Earnings per share was 0.28.

Revenue	2.74B
Gross Profit	2.30B
Operating Income	225.60M
Pretax Income	-27.23M
Net Income	37.13M
EBITDA	273.61M
EBIT	225.60M
Earnings Per Share (EPS)	0.28

Balance Sheet

The company has 2.32 billion in cash and 2.36 billion in debt, giving a net cash position of -41.49 million.

Cash & Cash Equivalents	2.32B
Total Debt	2.36B
Net Cash	-41.49M
Net Cash Per Share	n/a
Equity (Book Value)	199.35M
Book Value Per Share	1.51
Working Capital	2.04B

Cash Flow

In the last 12 months, operating cash flow was 226.60 million and capital expenditures -37.93 million, giving a free cash flow of 188.67 million.

Operating Cash Flow	226.60M
Capital Expenditures	-37.93M
Free Cash Flow	188.67M
FCF Per Share	n/a

Margins

Gross margin is 83.90%, with operating and profit margins of 8.25% and 1.36%.

Gross Margin	83.90%
Operating Margin	8.25%
Pretax Margin	-1.00%
Profit Margin	1.36%
EBITDA Margin	10.00%
EBIT Margin	8.25%
FCF Margin	6.90%

Dividends & Yields

ETR:DUL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.82%
Shareholder Yield	-4.82%
Earnings Yield	0.08%
FCF Yield	0.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:DUL has an Altman Z-Score of 4.46 and a Piotroski F-Score of 5.

Altman Z-Score	4.46
Piotroski F-Score	5